GlaxoSmithKline plcGSK-LN
Unknown · Drug Manufacturers - General
Scored 2026-07-08 · updates weekly
What’s driving the score
100 is the best score. The small percentage shows how much each factor counts. Hover a factor name for what it means. “n/a” means that factor doesn’t apply to this type of company (banks and REITs work differently), so the other factors count more.
The bottom line
As of 2026-07-08, GlaxoSmithKline (GSK-LN) scores 65.1 out of 100 on the Dividend Safety Checker scale, which rates its dividend Safe. In our testing, roughly 1 in 100 stocks with this rating cut their dividend within a year.
The strongest parts of the picture are debt load, dividend growth (1y), revenue growth. The main things holding the score back are years since last cut (scoring 53 out of 100) and profit steadiness (56 out of 100). How long since the company last cut its dividend. Long streaks tend to be defended.
GlaxoSmithKline currently yields 3.4%, last cut its dividend about 4 years ago, pays out 52% of its free cash flow as dividends. The score updates weekly as new filings and prices come in.
Common questions
Is GlaxoSmithKline's dividend safe?
As of 2026-07-08, GlaxoSmithKline (GSK-LN) scores 65.1 out of 100 on the Dividend Safety Checker scale, which rates its dividend Safe. In our testing, roughly 1 in 100 stocks with this rating cut their dividend within a year.
How likely is GSK-LN to cut its dividend in the next 12 months?
GlaxoSmithKline is rated Safe (score 65.1 of 100). In our testing, roughly 1 in 100 stocks with this rating cut their dividend within a year. The rating comes from a formula tested against every US dividend cut from 2008 to 2025.
When did GlaxoSmithKline last cut its dividend?
GlaxoSmithKline's last dividend cut was about 4 years ago, based on its payment history.
What is GlaxoSmithKline's dividend yield?
As of 2026-07-08, GlaxoSmithKline yields 3.4% based on its trailing 12 months of regular dividend payments.
How is this dividend safety score calculated?
The score combines 12 measurable factors: payout ratios, debt, profit steadiness, yield versus the stock's own history, and the company's cut record. Each factor is graded against 18 years of real dividend-cut history. The full method is public at dividendsafetychecker.com/methodology.
Answers are generated from the latest model run and refresh with each rescore. Not investment advice. See how the score works.
Get a free alert if GlaxoSmithKline's rating drops
We recheck GSK-LN and every stock we track each week. When any of them gets downgraded, subscribers hear about it first. No spam, unsubscribe anytime.
Share it
Download the score card as an image to post or send.
Want to know how this is calculated? The whole method is public, and so is its track record. Or browse more Unknown dividend stocks.